These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34100394)

  • 41. Pharmacokinetics of theophylline in neonates.
    Simons FE; Rigatto H; Simons KJ
    Semin Perinatol; 1981 Oct; 5(4):337-45. PubMed ID: 7302609
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Apnea of prematurity and caffeine pharmacokinetics: potential impact on hospital discharge.
    Doyle J; Davidson D; Katz S; Varela M; Demeglio D; DeCristofaro J
    J Perinatol; 2016 Feb; 36(2):141-4. PubMed ID: 26562367
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Comparison of caffeine citrate and aminophylline for treating primary apnea in premature infants].
    Xu JL; Wang RQ; Chen DM
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Nov; 16(11):1129-32. PubMed ID: 25406558
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Caffeine for preterm infants: Fixed standard dose, adjustments for age or high dose?
    Saroha V; Patel RM
    Semin Fetal Neonatal Med; 2020 Dec; 25(6):101178. PubMed ID: 33168464
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of caffeine in treatment of apnea in the low-birth-weight infant.
    Aranda JV; Gorman W; Bergsteinsson H; Gunn T
    J Pediatr; 1977 Mar; 90(3):467-72. PubMed ID: 14241
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methylxanthine for the prevention and treatment of apnea in preterm infants.
    Marques KA; Bruschettini M; Roehr CC; Davis PG; Fiander M; Soll R
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013830. PubMed ID: 37905735
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of prevention of caffeine citrate on cytokine profile and bronchopulmonary dysplasia in preterm infants with apnea.
    Kou C; Han D; Li Z; Wu W; Liu Z; Zhang Y; Gao Z
    Minerva Pediatr; 2020 Apr; 72(2):95-100. PubMed ID: 30961342
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Caffeine Administration to Prevent Apnea in Very Premature Infants.
    Armanian AM; Iranpour R; Faghihian E; Salehimehr N
    Pediatr Neonatol; 2016 Oct; 57(5):408-412. PubMed ID: 26976495
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Pharmacokinetics of theophylline and caffeine in premature infants with apnea (author's transl)].
    Riechert M; Lipowsky G; Stöckl H; Stiegler H
    Monatsschr Kinderheilkd; 1981 Dec; 129(12):697-702. PubMed ID: 7329425
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Duration of Caffeine for Apnea of Prematurity-A Randomized Controlled Trial.
    Prakash R; Pournami F; Prabhakar J; Nandakumar A; Nair PMC; Jain N
    Indian J Pediatr; 2021 Dec; 88(12):1174-1179. PubMed ID: 33625665
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Role of Caffeine in Noninvasive Respiratory Support.
    Dobson NR; Patel RM
    Clin Perinatol; 2016 Dec; 43(4):773-782. PubMed ID: 27837758
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Caffeine use in preterm infants: from magic to uncertainty.
    Álvarado Socarras JL
    Arch Argent Pediatr; 2018 Dec; 116(6):380-383. PubMed ID: 30457713
    [No Abstract]   [Full Text] [Related]  

  • 53. [Effect of caffeine citrate on early pulmonary function in preterm infants with apnea].
    Yu M; Huang JH; Zhu R; Zhang XZ; Wu WY; Wen XH
    Zhongguo Dang Dai Er Ke Za Zhi; 2016 Mar; 18(3):206-10. PubMed ID: 26975815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative Efficacy and Safety of Caffeine and Aminophylline for Apnea of Prematurity in Preterm (≤34 weeks) Neonates: A Randomized Controlled Trial.
    Shivakumar M; Jayashree P; Najih M; Lewis LES; Bhat Y R; Kamath A; Shashikala -
    Indian Pediatr; 2017 Apr; 54(4):279-283. PubMed ID: 28474588
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Caffeine Therapy in Preterm Infants: The Dose (and Timing) Make the Medicine.
    Rostas SE; McPherson C
    Neonatal Netw; 2019 Nov; 38(6):365-374. PubMed ID: 31712401
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Caffeine pharmacokinetics in preterm infants older than 2 weeks.
    Pearlman SA; Duran C; Wood MA; Maisels MJ; Berlin CM
    Dev Pharmacol Ther; 1989; 12(2):65-9. PubMed ID: 2714159
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Methylxanthines in apnea of prematurity.
    Aranda JV; Turmen T
    Clin Perinatol; 1979 Mar; 6(1):87-108. PubMed ID: 383366
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Caffeine versus theophylline for apnea in preterm infants.
    Steer PA; Henderson-Smart DJ
    Cochrane Database Syst Rev; 2000; (2):CD000273. PubMed ID: 10796190
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Population pharmacokinetics of caffeine in neonates and young infants.
    Thomson AH; Kerr S; Wright S
    Ther Drug Monit; 1996 Jun; 18(3):245-53. PubMed ID: 8738763
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Real-World Routine Use of Caffeine Citrate in Preterm Infants: A European Postauthorization Safety Study.
    Lista G; Fabbri L; Polackova R; Kiechl-Kohlendorfer U; Papagaroufalis K; Saenz P; Ferrari F; Lasagna G; Carnielli VP;
    Neonatology; 2016; 109(3):221-7. PubMed ID: 26820884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.